Results 281 to 290 of about 8,017,739 (402)

Mass drug administration coverage and its determinants for the elimination of onchocerciasis in Ulanga District, Tanzania. [PDF]

PLoS Negl Trop Dis
Mhiche AK, Gasarasi D, Kabona G, Hussein A, Mwingira UJ, Abade AM.   +5 more
europepmc   +1 more source

Recommendations for the Use of Disease‐Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review

Arthritis Care &Research, EarlyView.
Objective Autoimmune rheumatic diseases commonly affect individuals of childbearing age, with historically increased adverse pregnancy outcomes in this group. The advent of disease‐modifying antirheumatic drugs (DMARDs) has fostered more suitable conditions for pregnancy; however, this is accompanied by challenges in ensuring safe use in reproductive ...
Athena Chin, Alice Terrett, Mihye Kwon, Samuel Whittle, Catherine Hill   +4 more
wiley   +1 more source

Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination. [PDF]

PLoS Negl Trop Dis
Pietrow RE, Bjerum C, Koudou BG, Supali T, Budge PJ, Fischer PU, Nutman TB, Bennuru S.   +7 more
europepmc   +1 more source

Electrophysiologic Effects of Flecainide Relative to Serum and Tissue Concentrations in Rabbits After Chronic Drug Administration

, 1989
Kaichiro Kamiya, Ram Kannan, Afsaneh Matin-Asgari, Bramah N. Singh   +3 more
openalex   +1 more source

Association Between Sleep Disturbance and Subsequent Pain Interference in Patients With Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective This study investigated whether sleep disturbance can predict the extent to which pain interferes with daily functioning in patients with early rheumatoid arthritis (RA). Methods Data were from adults with early RA (joint symptoms ≤12 months) enrolled in the Canadian Early Arthritis Cohort between 2016 and 2023.
Burcu Aydemir, Orit Schieir, Marie‐France Valois, Lutfiyya N. Muhammad, Jing Song, Dorothy Dunlop, Rowland W. Chang, Susan J. Bartlett, Louis Bessette, Gilles Boire, Glen Hazlewood, Carol Hitchon, Janet Pope, Carter Thorne, Diane Tin, Vivian P. Bykerk, Yvonne C. Lee   +16 more
wiley   +1 more source

A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments. [PDF]

Open Forum Infect Dis
Maglione MA, Klausner JD, Wirnkar PK, Fallarme I, Lak R, Sysawang K, Fu N, Yagyu S, Motala A, Tolentino D, Hempel S.   +10 more
europepmc   +1 more source

A System for Anesthesia Drug Administration Using Barcode Technology: The Codonics Safe Label System and Smart Anesthesia Manager™

Anesthesia and Analgesia, 2015
S. Jelacic, A. Bowdle, B. Nair, Dolly Kusulos, Lynnette Bower, K. Togashi   +5 more
semanticscholar   +1 more source

Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study

Arthritis Care &Research, EarlyView.
Objective Social determinants of health (SDoH) can impact outcomes but are not routinely screened for in US outpatient rheumatology clinics. This study determined the feasibility of routine point‐of‐care SDoH screening among patients with systemic lupus erythematosus (SLE) and associated barriers and facilitators at the physician, care team, and ...
S. Sam Lim, Vijay R. Nadipelli, Michelle Bruno, Daphne Lew, Bernard Rubin, Charmayne M. Dunlop‐Thomas, Kelsey Hulcher, Kristi R. Mitchell, Lydia Demetriou, Jeff Berko, Jason Bao, Alfred H. J. Kim   +11 more
wiley   +1 more source

Exploring the impact of mobile and migrant populations on mass drug administration coverage and effectiveness in Africa: A scoping review protocol. [PDF]

PLoS One
Sangare M, Coulibaly YI, Ravichandran P, Diabate AF, Duguay C, Vlassoff C, Kulkarni MA, Krentel A.   +7 more
europepmc   +1 more source